药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

休市中 02-27 16:08:20

63.150

+4.800

+8.23%

最高63.400	最低59.100	成交量897.60万
今开59.100	昨收58.350	日振幅7.37%
总市值794.43亿	流通市值794.43亿	总股本12.58亿
成交额5.62亿	换手率0.71%	流通股本12.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":63.15,"timestamp":1772179700006,"preClose":58.35,"halted":0,"volume":8976042,"delay":0,"changeRate":0.08226221079691512,"floatShares":1258000000,"shares":1258000000,"eps":0.9458570582745296,"marketStatus":"休市中","change":4.8,"latestTime":"02-27 16:08:20","open":59.1,"high":63.4,"low":59.1,"amount":561840770,"amplitude":0.073693,"askPrice":63.2,"askSize":5000,"bidPrice":63.15,"bidSize":109000,"shortable":3,"etf":0,"ttmEps":1.1630454735030433,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":58.35,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":2.6681406767736084,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"1193991119","title":"药明合联与Earendil Labs就Wuxitecan-2有效载荷-连接子技术平台达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193991119","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193991119?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:14","pubTimestamp":1772183652,"startTime":"0","endTime":"0","summary":"药明合联（WuXi XDC）宣布与Earendil Labs建立战略合作伙伴关系，双方将围绕Wuxitecan-2有效载荷-连接子技术平台展开深度协作。此次合作旨在整合彼此在生物偶联技术领域的优势资源，共同推进新型抗体偶联药物（ADC）技术的开发与应用。\n通过本次战略联手，药明合联将借助Earendil Labs在创新有效载荷-连接子技术方面的专长，进一步拓展其ADC技术平台的能力边界。Wuxitecan-2作为新一代拓扑异构酶I抑制剂有效载荷，具有显著的治疗潜力，这项合作将加速其在癌症治疗领域的创新应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2614045007","title":"药明合联午前涨近8% 公司有望持续受益XDC CRDMO行业下游需求改善趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045007","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614045007?lang=zh_cn&edition=full","pubTime":"2026-02-27 11:55","pubTimestamp":1772164500,"startTime":"0","endTime":"0","summary":"　　药明合联盘中涨超8%，截至发稿，股价上涨7.54%，现报62.75港元，成交额3.01亿港元。2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-27/doc-inhpfnzn6798937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268","LU2488822045.USD","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009267?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03329","LU0640798160.USD","LU2778985437.USD","LU1251922891.USD","159938","09926","BK1141","02268","LU0588546209.SGD","LU0417516902.SGD","LU0417516571.SGD","IE00B543WZ88.USD","09939","LU0348784397.USD","LU1961090484.USD","02228","LU0348767384.USD","LU0634319403.HKD","LU0348827113.USD","LU1770034418.SGD","LU0417516738.SGD","BK1197","LU0348825331.USD","LU0540923850.HKD","02367","BK1207","BK1617","SG9999014674.SGD","BK1100","BK1161","01789","LU2476274720.SGD","LU1720050803.USD","LU0348766576.USD","LU2476274308.USD","HK0000165453.HKD","BK1515","01099","LU1794554557.SGD","LU2488822045.USD","09688","LU2399975544.HKD","BK1191","IE00BPRC5H50.USD","03933","01530","BK1147","02196","BK1588","06160"],"gpt_icon":0},{"id":"2614697009","title":"【券商聚焦】交银国际维持药明合联(02268)买入评级 指XDC赛道融资/BD开年延续较高热情","url":"https://stock-news.laohu8.com/highlight/detail?id=2614697009","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614697009?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:43","pubTimestamp":1772156610,"startTime":"0","endTime":"0","summary":"2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"1128119023","title":"港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119023","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128119023?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:40","pubTimestamp":1772156400,"startTime":"0","endTime":"0","summary":"2月27日，港股创新药概念股走强，$药明合联(02268)$涨超7%，$云顶新耀(01952)$、$再鼎医药(ZLAB)$涨近6%，$康方生物(09926)$、$药明生物(02269)$涨超4%，$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a5adfc15d956a00313fe91052a1cff8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK4548","BK1588","159992","BK4139","BK4526","VT","BK1141","BK1583","VXUS","LU2488822045.USD","01952","SG9999014674.SGD","09688","02268","ZLAB","BK4585","BK1574","BK4588","BK1161","06978"],"gpt_icon":0},{"id":"2614567008","title":"药明合联02月26日主力净流出958.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614567008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614567008?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093752,"startTime":"0","endTime":"0","summary":"02月26日, 药明合联股价跌8.69%，报收58.35元，成交金额5.0亿元，换手率0.66%，振幅10.41%，量比3.95。药明合联今日主力资金净流出958.1万元，上一交易日主力净流入335.0万元。该股近5个交易日下跌10.08%，主力资金累计净流出1675.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5857.5万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","BK1141","LU2488822045.USD"],"gpt_icon":0},{"id":"2614008526","title":"药明合联盘中异动 大幅跳水5.01%报60.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614008526?lang=zh_cn&edition=full","pubTime":"2026-02-26 14:06","pubTimestamp":1772085973,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时06分，药明合联股票出现波动，股价大幅下挫5.01%。截至发稿，该股报60.700港元/股，成交量429.846万股，换手率0.34%，振幅5.71%。资金方面，该股资金流入9895.07万港元，流出1.2869亿港元。药明合联股票所在的生物技术行业中，整体跌幅为3.94%。其相关个股中，百奥赛图-B、药捷安康-B、思路迪医药股份涨幅较大，振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B，振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2614081032","title":"每日卖空追踪 | 药明合联 02月25日卖空量成交32.9万股，卖空比例为16.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614081032?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008232,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月25日，跌1.01%，卖空量成交32.9万股，较上一交易日减少68.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163414a71d5a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2613875532","title":"每日卖空追踪 | 药明合联 02月23日卖空量成交11.3万股，卖空比例为10.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613875532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613875532?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835429,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月23日，涨2.21%，卖空量成交11.3万股，较上一交易日减少65.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163343a4be7d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2612847734","title":"药明合联02月16日遭主力抛售211.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612847734","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612847734?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:15","pubTimestamp":1771229731,"startTime":"0","endTime":"0","summary":"02月16日, 药明合联股价跌0.46%，报收65.00元，成交金额5556.5万元，换手率0.07%，振幅2.45%，量比0.20。药明合联今日主力资金净流出211.9万元，上一交易日主力净流出960.0万元。该股近5个交易日上涨3.59%，主力资金累计净流出1103.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2520.9万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161642a700d466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2610926836","title":"每日卖空追踪 | 药明合联 02月12日卖空量成交25.95万股，卖空比例为6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610926836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610926836?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885029,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月12日，跌1%，卖空量成交25.95万股，较上一交易日减少64.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163402a49b9f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2610154489","title":"大行评级丨野村：上调药明合联目标价至87.73港元，预计今年盈利将升47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610154489","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610154489?lang=zh_cn&edition=full","pubTime":"2026-02-12 14:07","pubTimestamp":1770876421,"startTime":"0","endTime":"0","summary":"野村发表研报，将药明合联2025年收入及盈利预测分别下调4.5%及8.7%，以反映公司上月公布的实际数据。同时，该行预计来自商业化阶段项目的收入为1.81亿元，而收购东曜药业带来的收入则为1.5亿元。利润方面，该行预计2026年盈利将升47%；毛利率按年扩张0.7个百分点至36.5%，基于规模经济效应，但新加坡厂房的折旧将带来轻微拖累；经营利润率按年扩张1.1个百分点至29.3%，反映效率提升。该行将药明合联目标价由82.72港元上调至87.73港元，评级“买入”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260212/32014586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02268"],"gpt_icon":0},{"id":"1144275849","title":"药明合联(2268)、东曜药业(1875)联合公告：寄发自愿有条件现金要约综合文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1144275849","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144275849?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:52","pubTimestamp":1770850322,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司与东曜药业股份有限公司于2026年2月12日联合发布公告，宣布寄发有关自愿有条件现金要约的综合文件。该要约由花旗环球金融亚洲有限公司代表要约人，拟收购除要约人及其一致行动人士已拥有或同意收购以外的全部已发行股份，并注销全部尚未行使的购股权。综合文件包含要约详情、独立董事委员会及独立财务顾问意见、接受程序及预期时间表等内容。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2610710967","title":"药明合联生物技术有限公司与东曜药业股份有限公司联合公告：要约收购相关事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2610710967","media":"金吾财讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610710967?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:43","pubTimestamp":1770849815,"startTime":"0","endTime":"0","summary":"公告指出，综合文件及随附的接纳表格将于2026年2月12日寄送给股东和购股权持有人，要约亦于同日正式启动。同时，公告提醒股东、受限制股份奖励持有人和购股权持有人，在收到综合文件及随附的接纳表格后，应仔细阅读相关内容，并根据独立财务顾问的意见及独立董事委员会的建议，审慎决定是否接受要约。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212070618a499a13a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212070618a499a13a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1161","02268","BK1141","BK1574","01875"],"gpt_icon":1},{"id":"1175233464","title":"药明合联(2268)拟以每股4港元收购东曜药业(1875)全部股份并注销未行使购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1175233464","media":"公告速递","labels":["corporation","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175233464?lang=zh_cn&edition=full","pubTime":"2026-02-12 06:41","pubTimestamp":1770849670,"startTime":"0","endTime":"0","summary":"2026年2月12日，药明合联生物技术有限公司与东曜药业股份有限公司联合公布一份自愿有条件现金要约方案。公告显示，药明合联方面通过财务顾问花旗环球金融亚洲有限公司，提议以每股4.00港元的现金价格收购东曜药业已发行的所有股份，并同时注销全部未行使的购股权。本次收购要约价较东曜药业在公告前的部分平均价格有溢价，药明合联某些股东同时也签订缺额承诺，以确保在接纳不足时可再行提出接纳。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2610250289","title":"医药行业周报：1-8批国采平稳接续扰动有限 机构加仓创新 持续看好低估创新标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2610250289","media":"交银国际","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610250289?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:00","pubTimestamp":1770825600,"startTime":"0","endTime":"0","summary":"本周内外资继续重点加仓创新药械产业链：1）内资重点加仓泰格医药、康龙化成、药明生物等受益于需求复苏的龙头CXO 企业，以及一脉阳光、方舟健客等AI 赋能的器械和服务类标的；2 外资亦加仓低估值创新药械企业，包括亿腾生物、石药集团和MIRXES 等，以及凯莱英、昭衍新药等CXO 企业。投资启示：本周1-8 批国采平稳接续，整体中选率高达93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212202658a6f36bb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212202658a6f36bb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","LU2488822045.USD","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2610984330","title":"每日卖空追踪 | 药明合联 02月10日卖空量成交14.95万股，卖空比例为2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610984330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610984330?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712231,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月10日，涨3.51%，卖空量成交14.95万股，较上一交易日减少35.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163422a6e9add0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163422a6e9add0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2610268695","title":"恒生医疗保健指数升2.17%  医药板块普遍拉升 机构持续看好中国创新药出海的产业趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610268695?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f73ea90e21e93e4b02cf2f8986a9c30","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","02696","BK1161","LU2476274720.SGD","02359","LU1720050803.USD","06990","LU1046422090.SGD","LU0572944931.SGD","LU0181495838.USD","LU0417516738.SGD","09688","159506","LU0359202008.SGD","LU2039709279.SGD","09995","LU0417516902.SGD","LU0043850808.USD","LU2488822045.USD","LU0348825331.USD","09969","159992","LU0516423174.USD","01801","IE00B5MMRT66.SGD","02162","LU0502904849.HKD","LU2242644610.SGD","LU0634319403.HKD","LU0140636845.USD","LU2476274308.USD","LU0856984785.SGD","BK1587","01548","HK0000306701.USD","LU0516422366.SGD","LU1969619763.USD","LU1688375341.USD","LU1961090484.USD","159938","02269","09926","LU0051755006.USD","LU0823426308.USD","LU2045819591.USD","06978","LU0196878994.USD","09939","01877","02268"],"gpt_icon":1},{"id":"2610568695","title":"高盛：今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568695?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:08","pubTimestamp":1770617323,"startTime":"0","endTime":"0","summary":"今年要获得超越行业的回报，更依赖于关键数据公布、实际成交，以及盈利兑现或转折点的能见度。该行对医疗器械板块维持中性看法，虽然行业已触底，但需时逐步复苏；推荐买时代天使及威高股份。医疗服务板块方面，该行仍持相对谨慎态度，因成本控制措施的持续影响，以及疲弱的消费周期；下调海吉亚医疗评级至“中性”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0708995583.HKD","BK1161","BK1589","02359","BK4139","HK0000165453.HKD","LU0196878994.USD","BK1576","06990","LU2488822045.USD","159891","CDMO","LU2125910500.SGD","03692","HK0000320223.HKD","02696","LU1046422090.SGD","HK0000306685.HKD","02268","HK0000320264.USD","LU2045819591.USD","HK0000306701.USD","BK1141","LU0320764599.SGD","SG9999014674.SGD","LU2242644610.SGD","BK1191","LU0052750758.USD","BK1583"],"gpt_icon":0},{"id":"2609690505","title":"每日卖空追踪 | 药明合联 02月06日卖空量成交16.1万股，卖空比例为3.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609690505","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609690505?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366630,"startTime":"0","endTime":"0","summary":"药明合联北京时间02月06日，涨1.45%，卖空量成交16.1万股，较上一交易日减少72.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163440a483cf24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163440a483cf24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":-0.0359},{"period":"1month","weight":-0.0344},{"period":"3month","weight":-0.0351},{"period":"6month","weight":0.1157},{"period":"1year","weight":0.8465},{"period":"ytd","weight":0.0395}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}